Evli’s and OP’s reports are generally more pleasant for an owner to read, as many analysts at Inderes (unlike in 2021) often have quite gloomy [views]..It’s easy to stop reading in the middle of a “lament.”
Evli: Solteq’s Q3 fell slightly short of our expectations.
Earnings guidance for 2025 remained
Comparable revenue decreases slightly and comparable operating profit improves clearly. Comparable revenue, excluding the sold healthcare software solutions business, was 48,818 thousand euros in the fiscal year 2024. Comparable operating profit was 710 thousand euros in the fiscal year 2024.